imipramine has been researched along with Obesity in 6 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 kg/m(2) [SD]) was designed to assess whether diet counseling with psychological support and imipramine or placebo has an effect on the frequency of binge eating, body weight, and depression during an 8-week treatment phase." | 5.09 | Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. ( Graf, C; Horber, F; Laederach-Hofmann, K; Lederer, S; Lippuner, K; Michel, R; Schneider, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, KD | 1 |
| CHIMENES, H | 1 |
| Fogelson, DL | 1 |
| Laederach-Hofmann, K | 1 |
| Graf, C | 1 |
| Horber, F | 1 |
| Lippuner, K | 1 |
| Lederer, S | 1 |
| Michel, R | 1 |
| Schneider, M | 1 |
| Alger, SA | 1 |
| Schwalberg, MD | 1 |
| Bigaouette, JM | 1 |
| Michalek, AV | 1 |
| Howard, LJ | 1 |
| Klotz, HP | 1 |
2 trials available for imipramine and Obesity
| Article | Year |
|---|---|
Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study.
Topics: Adrenergic Uptake Inhibitors; Adult; Counseling; Depression; Double-Blind Method; Energy Intake; Fee | 1999 |
Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects.
Topics: Adult; beta-Endorphin; Bulimia; Double-Blind Method; Female; Humans; Hyperphagia; Imipramine; Naltre | 1991 |
4 other studies available for imipramine and Obesity
| Article | Year |
|---|---|
Anxiety in youth.
Topics: Adolescent; Anxiety Disorders; Child; Comorbidity; Cross-Sectional Studies; Humans; Imipramine; Impl | 2010 |
[VALUE OF IMIPRAMINE IN THE TREATMENT OF OBESITY].
Topics: Humans; Imipramine; Obesity; Psychosomatic Medicine | 1964 |
Fenfluramine and the cytochrome P450 system.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fenfl | 1997 |
[Therapeutic reflections on obesity. Psychosocial aspect].
Topics: Appetite Depressants; Diet, Reducing; Diuretics; Humans; Imipramine; Obesity; Pituitary Hormones, An | 1969 |